Australia markets closed

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
33.94-0.27 (-0.79%)
At close: 04:00PM EDT
32.28 -1.66 (-4.89%)
After hours: 07:47PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts7777
Avg. Estimate-0.87-0.89-2.99-3.2
Low estimate-1.06-1.17-3.5-4.08
High estimate-0.41-0.4-2.5-2.58
Year ago EPS-0.47-0.25-1.24-2.99
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts7777
Avg. Estimate34.35M35.62M130.77M161.16M
Low estimate31.5M34.1M121M153.9M
High estimate35.77M36.89M134.2M167.6M
Year ago salesN/A25.04M94.08M130.77M
Sales growth (year/est)N/A42.30%39.00%23.20%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-0.4-0.47-0.71-0.76
Actual EPS-0.47-0.25-0.97-0.06
Difference-0.070.22-0.260.7
Surprise %-17.50%46.80%-36.60%92.10%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-0.87-0.89-2.99-3.2
7 days ago-0.8-0.82-3.33-2.93
30 days ago-0.8-0.82-3.39-2.93
60 days ago-0.8-0.82-3.39-2.93
90 days ago-0.79-0.82-3.33-2.94
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 days1153
Up last 30 days1153
Down last 7 daysN/AN/AN/AN/A
Down last 30 days4513
Growth estimatesCSTLIndustrySector(s)S&P 500
Current qtr.-85.10%N/AN/AN/A
Next qtr.-256.00%N/AN/AN/A
Current year-141.10%N/AN/AN/A
Next year-7.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A